Who is sponsoring NCT03899454?

NCT03899454 is sponsored by Universitas Negeri Semarang.

What condition does NCT03899454 study?

NCT03899454 studies Exertion; Excess, Oxidative Stress.

Is NCT03899454 still recruiting?

NCT03899454 is currently status unknown. Last updated 30 July 2019.

Last reviewed 2019-07-30 · How we verify

NCT03899454: GMR-RCT-EOS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Garcinia Mangostana L Rind and Solanum Lycopersicum Fructus Trial to Prevent Exercise-induced Oxidative Stress

Status unknown Phase 2, PHASE3 Last updated 30 July 2019

What this trial tests

Phase 2, PHASE3 trial testing Garcinia-mangostana-L-rind and Solanum-Lycopersicum-Fructus mixture-extract in Exertion; Excess in 30 participants. Status unknown.

Timeline

15 July 2020

Primary endpoint
15 September 2020

15 September 2022

Quick facts

Lead sponsor	Universitas Negeri Semarang
Phase	Phase 2, PHASE3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	30
Start date	15 July 2020
Primary completion	15 September 2020
Estimated completion	15 September 2022
Sites	1 location across Indonesia

Drugs / interventions tested

Garcinia-mangostana-L-rind and Solanum-Lycopersicum-Fructus mixture-extract — full drug profile →
Placebo Control

Conditions studied

Exertion; Excess — all drugs for Exertion; Excess →
Oxidative Stress — all drugs for Oxidative Stress →

Sponsor

Universitas Negeri Semarang — full company profile →

Who can join

Adults 18 to 25, male only, with Exertion; Excess or Oxidative Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Treatments are an administration of a mixed extract of Garcinia mangostana 400mg and Solanum Lycopersicum Fructus 200mg (OKSI(R) POM TR 193324351) and placebo control.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Universitas Negeri Semarang trials

Trials by the same sponsor.

NCT03310450 — Tour de Borobudur Troponin Study on Predictors and Synergistic Role of MDA and Hs-CRP Levels · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03899454 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universitas Negeri Semarang
Last refreshed: 30 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03899454.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing